Related Experiment Video
Updated: Jul 24, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Application of the multiphase optimisation strategy (MOST) to optimise HIV prevention targeting people on medication
Colleen B Mistler1,2, Roman Shrestha3,4, John Gunstad5
1Department of Allied Health Sciences, University of Connecticut, Storrs, Connecticut, USA colleen.mistler@uconn.edu.
Introduction:
People who inject drugs (PWID) have remained a contributor to the consistent HIV incidence rates in the US for decades. Pre-exposure prophylaxis (PrEP) is a promising biomedical intervention for HIV prevention among individuals at risk for HIV infection, including PWID. However, PWID report the lowest rates of PrEP uptake and adherence among at-risk groups. Tailored HIV prevention interventions must include strategies that compensate for cognitive dysfunction among PWID.
Methods And Analysis:
Using the multiphase optimisation strategy, we will be conducting a 16-condition factorial experiment to investigate the effects of four different accommodation strategy components to compensate for cognitive dysfunction among 256 PWID on medication for opioid use disorder. This innovative approach will inform optimisation of a highly effective intervention to enhance PWID's ability to process and utilise HIV prevention content to improve PrEP adherence and HIV risk reduction in a drug treatment setting.
Ethics And Dissemination:
The institutional review board at the University of Connecticut approved this protocol (H22-0122) with an institutional reliance agreement with APT Foundation Inc. All participants are required to sign an informed consent form prior to engaging in any study protocols. The results of this study will be disseminated on national and international platforms through presentations at major conferences and journals.
Trial Registration Number:
NCT05669534.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Retrovirus Life Cycles
Drug Therapy
Antianxiety Medications
Analysis of Population Pharmacokinetic Data
Factors Affecting Drug Response: Overview
Psychosis: Goals of Pharmacotherapy

